225 related articles for article (PubMed ID: 30604052)
1. Profiling of lipidomics before and after antipsychotic treatment in first-episode psychosis.
Leppik L; Parksepp M; Janno S; Koido K; Haring L; Vasar E; Zilmer M
Eur Arch Psychiatry Clin Neurosci; 2020 Feb; 270(1):59-70. PubMed ID: 30604052
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics approach revealed robust changes in amino acid and biogenic amine signatures in patients with schizophrenia in the early course of the disease.
Parksepp M; Leppik L; Koch K; Uppin K; Kangro R; Haring L; Vasar E; Zilmer M
Sci Rep; 2020 Aug; 10(1):13983. PubMed ID: 32814830
[TBL] [Abstract][Full Text] [Related]
3. Anterior Hippocampal-Cortical Functional Connectivity Distinguishes Antipsychotic Naïve First-Episode Psychosis Patients From Controls and May Predict Response to Second-Generation Antipsychotic Treatment.
Blessing EM; Murty VP; Zeng B; Wang J; Davachi L; Goff DC
Schizophr Bull; 2020 Apr; 46(3):680-689. PubMed ID: 31433843
[TBL] [Abstract][Full Text] [Related]
4. [Membrane lipids in schizophrenia and early phases of psychosis: Potential biomarkers and therapeutic targets?].
Frajerman A; Kebir O; Chaumette B; Tessier C; Lamazière A; Nuss P; Krebs MO
Encephale; 2020 Jun; 46(3):209-216. PubMed ID: 32151446
[TBL] [Abstract][Full Text] [Related]
5. Association Between Circulating Lipids and Future Weight Gain in Individuals With an At-Risk Mental State and in First-Episode Psychosis.
Lamichhane S; Dickens AM; Sen P; Laurikainen H; Borgan F; Suvisaari J; Hyötyläinen T; Howes O; Hietala J; Orešič M
Schizophr Bull; 2021 Jan; 47(1):160-169. PubMed ID: 32609372
[TBL] [Abstract][Full Text] [Related]
6. Trajectory of neurological examination abnormalities in antipsychotic-naïve first-episode psychosis population: a 1 year follow-up study.
Lizano P; Dhaliwal K; Lutz O; Mothi SS; Miewald J; Montrose D; Keshavan M
Psychol Med; 2020 Sep; 50(12):2057-2065. PubMed ID: 31451118
[TBL] [Abstract][Full Text] [Related]
7. Contrasting Case-Control and Normative Reference Approaches to Capture Clinically Relevant Structural Brain Abnormalities in Patients With First-Episode Psychosis Who Are Antipsychotic Naive.
Remiszewski N; Bryant JE; Rutherford SE; Marquand AF; Nelson E; Askar I; Lahti AC; Kraguljac NV
JAMA Psychiatry; 2022 Nov; 79(11):1133-1138. PubMed ID: 36169987
[TBL] [Abstract][Full Text] [Related]
8. Innate Immune Cells and C-Reactive Protein in Acute First-Episode Psychosis and Schizophrenia: Relationship to Psychopathology and Treatment.
Steiner J; Frodl T; Schiltz K; Dobrowolny H; Jacobs R; Fernandes BS; Guest PC; Meyer-Lotz G; Borucki K; Bahn S; Bogerts B; Falkai P; Bernstein HG
Schizophr Bull; 2020 Feb; 46(2):363-373. PubMed ID: 31504969
[TBL] [Abstract][Full Text] [Related]
9. Prolactin and morning cortisol concentrations in antipsychotic naïve first episode psychosis: A systematic review and meta-analysis.
Aymerich C; Pedruzo B; Pacho M; Laborda M; Herrero J; Pillinger T; McCutcheon RA; Alonso-Alconada D; Bordenave M; Martínez-Querol M; Arnaiz A; Labad J; Fusar-Poli P; González-Torres MÁ; Catalan A
Psychoneuroendocrinology; 2023 Apr; 150():106049. PubMed ID: 36758330
[TBL] [Abstract][Full Text] [Related]
10. Alteration in NMDAR-related amino acids in first episode psychosis.
Garip B; Kayir H
Synapse; 2019 Nov; 73(11):e22127. PubMed ID: 31403728
[TBL] [Abstract][Full Text] [Related]
11. Aging biological markers in a cohort of antipsychotic-naïve first-episode psychosis patients.
Talarico F; Xavier G; Ota VK; Spindola LM; Maurya PK; Tempaku PF; Moretti PS; Gadelha A; Noto M; Noto C; Cordeiro Q; Bressan RA; de Jong S; Santoro ML; Breen G; Belangero SI
Psychoneuroendocrinology; 2021 Oct; 132():105350. PubMed ID: 34271521
[TBL] [Abstract][Full Text] [Related]
12. Isolating the impact of antipsychotic medication on metabolic health: Secondary analysis of a randomized controlled trial of antipsychotic medication versus placebo in antipsychotic medication naïve first-episode psychosis (the STAGES study).
O'Donoghue B; Allott K; Harrigan S; Scalzo F; Ward J; Mallawaarachchi S; Whitson S; Baldwin L; Graham J; Mullen E; MacNeil C; Alexander D; Wood SJ; Berk M; Alvarez-Jimenez M; Thompson A; Fornito A; Yuen HP; Nelson B; Francey SM; McGorry P
Early Interv Psychiatry; 2023 Jun; 17(6):597-607. PubMed ID: 36196478
[TBL] [Abstract][Full Text] [Related]
13. Plasma amino acids profile in first-episode psychosis, unaffected siblings and community-based controls.
Loureiro CM; da Roza DL; Corsi-Zuelli F; Shuhama R; Fachim HA; Simões-Ambrosio LMC; Deminice R; Jordão AA; Menezes PR; Del-Ben CM; Louzada-Junior P
Sci Rep; 2020 Dec; 10(1):21423. PubMed ID: 33293633
[TBL] [Abstract][Full Text] [Related]
14. Qualitative distribution of endogenous phosphatidylcholine and sphingomyelin in serum using LC-MS/MS based profiling.
Hu B; Song C; Li L; Wang M; Jia S; Li S; Du Z; Ding X; Jiang H
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Oct; 1155():122289. PubMed ID: 32771970
[TBL] [Abstract][Full Text] [Related]
15. Immuno-inflammatory changes across phases of early psychosis: The impact of antipsychotic medication and stage of illness.
Kelsven S; de la Fuente-Sandoval C; Achim CL; Reyes-Madrigal F; Mirzakhanian H; Domingues I; Cadenhead K
Schizophr Res; 2020 Dec; 226():13-23. PubMed ID: 32089474
[TBL] [Abstract][Full Text] [Related]
16. BDNF in antipsychotic naive first episode psychosis: Effects of risperidone and the immune-inflammatory response system.
Noto MN; Maes M; Vargas Nunes SO; Ota VK; Cavalcante D; Oliveira G; Rossaneis AC; Verri WA; Cordeiro Q; Belangero SI; Gadelha A; Noto C; Bressan RA
J Psychiatr Res; 2021 Sep; 141():206-213. PubMed ID: 34246975
[TBL] [Abstract][Full Text] [Related]
17. Weight and metabolic changes in early psychosis-association with daily quantification of medication exposure during the first hospitalization.
Vochoskova K; McWhinney SR; Fialova M; Kolenic M; Spaniel F; Svancer P; Boron P; Okaji Y; Trancik P; Hajek T
Acta Psychiatr Scand; 2023 Sep; 148(3):265-276. PubMed ID: 37528692
[TBL] [Abstract][Full Text] [Related]
18. Neurometabolic correlates of 6 and 16 weeks of treatment with risperidone in medication-naive first-episode psychosis patients.
Birur B; Kraguljac NV; VerHoef L; Morgan CJ; Jindal RD; Reid MA; Luker A; Lahti AC
Transl Psychiatry; 2020 Jan; 10(1):15. PubMed ID: 32066680
[TBL] [Abstract][Full Text] [Related]
19. Visual Cortical Alterations and their Association with Negative Symptoms in Antipsychotic-Naïve First Episode Psychosis.
Adhan I; Lizano P; Bannai D; Lutz O; Dhaliwal K; Zeng V; Miewald J; Montrose D; Keshavan M
Psychiatry Res; 2020 Jun; 288():112957. PubMed ID: 32325384
[TBL] [Abstract][Full Text] [Related]
20. Early treatment-related changes in diabetes and cardiovascular disease risk markers in first episode psychosis subjects.
Graham KA; Cho H; Brownley KA; Harp JB
Schizophr Res; 2008 Apr; 101(1-3):287-94. PubMed ID: 18255275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
